Investigating IL-31 as a Novel Candidate Pathway for Prurigo Nodularis (PN)
Time: 12:05 pm
day: Day One
Details:
- Exploring the scientific rationale for investigating IL-31 in PN
- Unravelling key findings in phase 2 clinical data
- Elucidating the mechanism of action of nemolizumab in PN using a multi-omics approach
